Tianjin Key Laboratory of Artificial Cell Tianjin Institute of Hepatobiliary Disease Nankai University Affiliated Third Center Hospital Tianjin China.
Tianjin Medical University Third Center Clinical College Tianjin China.
J Extracell Vesicles. 2021 Apr;10(6):e12065. doi: 10.1002/jev2.12065. Epub 2021 Apr 10.
Extracellular vesicles that are derived from stem cells play an important role in the treatment of disease. To obtain high-quality small extracellular vesicles (sEVs), we optimized the culture conditions of human induced pluripotent stem cells (hiPSCs), the supernatant collection time, and sEVs extraction methods. Firstly, hiPSCs were cultured in extracellular vesicles-production medium (EVs-PM) containing different concentrations (0%, 0.25%, 0.5%, 2%, 5%, and 20%) of extracellular vesicle-depleted knockout serum replacement (ED-KSR), and the culture supernatants were collected continuously for 5 days. Then, the sEVs were isolated, followed by an evaluation of their characteristics. The survival rates of the hiPSCs lines that were cultured in EVs-PM containing 0.5% to 20% ED-KSR were not significantly different (> 0.05). The survival rates of the hiPSCs in 0.5% ED-KSR after the culture supernatants were continuously collected for day 1, day 3, and day 5 were not statistically significant (> 0.05). After 5 days of continuous collection of the supernatant, the hiPSCs expressed some pluripotent markers, while SSEA4 and TRA-1-60 expression changed gradually. The sEVs that were extracted by the two methods were all 50-200 nm, double-layered and oval or round cellular vesicles and expressed the marker proteins CD63, TSG101, and HSP70. The characteristics of sEVs extracted on day 1, day 3, and day 5 were almost identical on morphology, size and the relative quantity of annexin V-positive subpopulations. The PKH67 staining showed that the sEVs could be endocytosed by HepG2 cells and aggregated in the cytoplasm. The proliferation experiments showed that the sEVs can promote cell proliferation. In Conclusion, the 0.5% ED-KSR is the optimal concentration, and that the hiPSCs culture supernatant can be continuously collected for 5 days while maintaining high cell viability and some pluripotent characteristics. Both of the methods extraction can be used to obtain biologically active sEVs.
由干细胞衍生的细胞外囊泡在疾病治疗中发挥着重要作用。为了获得高质量的小细胞外囊泡(sEVs),我们优化了人诱导多能干细胞(hiPSCs)的培养条件、上清液收集时间和 sEVs 提取方法。首先,将 hiPSCs 在含有不同浓度(0%、0.25%、0.5%、2%、5%和 20%)细胞外囊泡耗尽型无外泌体血清替代物(ED-KSR)的细胞外囊泡生产培养基(EVs-PM)中培养,并连续收集培养上清液 5 天。然后,分离 sEVs,并对其特性进行评估。在含有 0.5%至 20% ED-KSR 的 EVs-PM 中培养的 hiPSC 系的存活率无显著差异(>0.05)。在连续收集培养上清液 1 天、3 天和 5 天后,0.5% ED-KSR 中 hiPSC 的存活率无统计学意义(>0.05)。连续收集上清液 5 天后,hiPSCs 表达了一些多能标志物,而 SSEA4 和 TRA-1-60 的表达逐渐变化。通过两种方法提取的 sEVs 均为 50-200nm,双层,椭圆形或圆形细胞囊泡,并表达标记蛋白 CD63、TSG101 和 HSP70。在形态、大小和 Annexin V 阳性亚群的相对数量方面,第 1 天、第 3 天和第 5 天提取的 sEVs 特征几乎相同。PKH67 染色表明 sEVs 可被 HepG2 细胞内化并聚集在细胞质中。增殖实验表明 sEVs 可促进细胞增殖。综上所述,0.5% ED-KSR 是最佳浓度,hiPSCs 培养上清液可连续收集 5 天,同时保持高细胞活力和一些多能特征。两种方法的提取都可以获得具有生物活性的 sEVs。